As Nigeria grapples with a faltering economy, high inflation, and a depreciating currency, a development expert, Dr Segun ...

On her highly anticipated fourth album, the New Zealand pop sensation challenges both her and our understanding of modern ...

The original meaning behind the cards, first created 500 years ago, still remains elusive. But that didn't stop our reporter ...

Supermassive black holes usually lurk unseen, but when an unlucky star drifts too close they ignite titanic outbursts ...

Researchers at the University Medical Center Göttingen (UMG) and the Göttingen Cluster of Excellence "Multiscale Bioimaging" (MBExC) have shown how a minimal change in a single ion channel increases ...

Called RisingAttacK, the method is effective at manipulating all of the most widely used AI computer vision systems.

LOFAR is a massive radio telescope that comprises 100,000 antennas spread across eight European countries. The researchers ...

See the latest Dentsply Sirona Inc stock price (XRAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Mather Hospital unveils a $78M emergency department designed for aging adults, and to provide faster care, privacy and ...

Review quarterly and annual revenue, net income, and cash flow for Dentsply Sirona Inc (XRAY:XNAS) stock through the last fiscal year.

After losing Roche as a partner, Blueprint Medicines has sold US commercial rights to RET inhibitor Gavreto to Rigel Pharma in a deal worth up to $117.5 million.